Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer

By sjmartinez • July 14, 2024

Preston MA, Ebrahimi R, Hong A, Bobbili P, Desai R, Duh MS, Gandhi R, Hanson S, Dufour R, Morgans AK. Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer. Urol Oncol. 2024 Jul 12:S1078-1439(24)00499-X. doi: 10.1016/j.urolonc.2024.05.026. Epub ahead of print. PMID: 39003108.

Tags: Androgen deprivation therapy, Cardiology/Epi, cardiovascular risk, Continuous ADT, Endocrine or metabolic risk, Intermittent ADT, Nonmetastatic prostate cancer, Publications, Veterans Administration

In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure

Arshad MS, Jamil A, Greene SJ, Van Spall HGC, Fonarow GC, Butler J, Khan MS. In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute[...]

Anti-Inflammatory Oxysterol, Oxy210, Inhibits Atherosclerosis in Hyperlipidemic Mice and Inflammatory Responses of Vascular Cells

Stappenbeck F, Wang F, Sinha SK, Hui ST, Farahi L, Mukhamedova N, Fleetwood A, Murphy AJ, Sviridov D, Lusis AJ, Parhami F. Anti-Inflammatory Oxysterol, Oxy210,[...]

Calcified aneurysm in the left anterior descending artery

Bishay R, Krishnan S, Budoff MJ. Calcified aneurysm in the left anterior descending artery. Coron Artery Dis. 2024 Oct 15. doi: 10.1097/MCA.0000000000001436. Epub ahead of[...]